PT-141 serves as a cutting-edge cyclic melanocortin agonist that possesses potential in the treatment of sexual dysfunction. This novel compound operates by stimulating specific receptors within the body, resulting to improved sexual response. Research studies have suggested that PT-141 has the potential to significantly address a range of sexual